ACSL1 and obesity disorder: In obesity-related kidney disease models, the downregulation of long-chain acyl-CoA synthetase-1 (ACSL1), a vital enzyme in fatty acid oxidation, is closely linked to heightened lipid accumulation in the kidneys (54).